Is treatment-resistant schizophrenia a neuroimmune condition? Meta-analytic evidence from magnetic resonance spectroscopy
- PMID: 39025951
- PMCID: PMC11525476
- DOI: 10.1038/s41386-024-01932-0
Is treatment-resistant schizophrenia a neuroimmune condition? Meta-analytic evidence from magnetic resonance spectroscopy
Erratum in
-
Correction: Neuropsychopharmacology Volume 50 Issue 1.Neuropsychopharmacology. 2025 May;50(6):1019-1020. doi: 10.1038/s41386-025-02087-2. Neuropsychopharmacology. 2025. PMID: 40108440 Free PMC article. No abstract available.
Conflict of interest statement
The authors declare no competing interests.
References
-
- de Bartolomeis A, Ciccarelli M, Vellucci L, Fornaro M, Iasevoli F, Barone A. Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia. Expert Opin Pharmacother. 2022;23:2035–52. - PubMed
Publication types
Grants and funding
- P50 MH106438/MH/NIMH NIH HHS/United States
- MH125096/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- MH059883/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- K01 MH125096/MH/NIMH NIH HHS/United States
- MH106438/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
LinkOut - more resources
Full Text Sources
